Clinical Trial Update: Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing once-daily versus twice-daily insulin detemir injections for metabolic control in people with Type 1 diabetes, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED